Radiotherapy for early vocal cord cancer: a dosimetric analysis of 60CO versus 6 MV photons.
Currently, many patients with early vocal cord cancers are treated with 6 MV photons, but almost all the published radiotherapy data are based on patients treated with 60Co, 2-MV, or 4-MV X-rays. A theoretical risk of underdosage exists with higher energy beams due to lack of dose build-up. This dosimetric study compares 6-MV photons with 60Co. A tissue-equivalent phantom was constructed of a stack of 0.5-cm-thick acrylic plates. With a male subject in treatment position as the model, the external surfaces of the phantom were machined to match the contour of the neck. To precisely represent the internal contour of the airway, computed tomography (CT) was performed on the subject in treatment position, with images at 0.5-cm intervals, and the airway shown on the CT was cut out of each corresponding acrylic plate. Thermoluminescent dosimetry (TLD) rods were inserted into the phantom. For each measurement, a calculated tumor dose of 10 Gy was delivered to the volume specified as the entire right true vocal cord in the phantom, with either 60Co or 6-MV photons (15 measurements were made with each). In a second series of eight experiments with each modality, TLD minichips were used to measure the dose received by the immediate surface of the vocal cords with delivery of a calculated tumor dose of 0.5 Gy. The doses received at the vocal cords, as well as a point 6 mm beneath the anterior skin surface, did not differ significantly for the two energies compared. The dose delivered to the skin and a point 3 mm beneath the anterior skin surface was significantly lower with the use of 6-MV photons. Although there is no difference in the dose received by the vocal cords, underdosage of the anterior tissues may occur with the use of 6-MV photons.